Results 101 to 110 of about 1,483,959 (183)

Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriage [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2010
Kaandorp, S. P.   +7 more
openaire   +3 more sources

Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease

open access: yesJACC: CardioOncology, 2021
Tetsuro Yokokawa   +8 more
openaire   +2 more sources

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes. [PDF]

open access: yesBlood Adv, 2023
Rafati M   +17 more
europepmc   +1 more source

Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm. [PDF]

open access: yesNat Commun, 2022
Al-Rifai R   +26 more
europepmc   +1 more source

Evaluation of JAK2V617F mutation prevalence in Myeloproliferative Neoplasm by AS-RT-PCR

open access: yesپیاورد سلامت, 2009
Background and Aim: The JAK2 is an acquired mutation that is observed in majority of patients with classical Philadelphia-negative Myeloproliferative neoplasms that include polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF).
B Bahar   +8 more
openaire   +2 more sources

Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation. [PDF]

open access: yesChin Med J (Engl), 2021
Shen HX   +5 more
europepmc   +1 more source

JAK2V617F mutation in patients with thrombosis: to screen or not to screen? [PDF]

open access: yesInternational Journal of Laboratory Hematology, 2010
S. G. XAVIER   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy